First Results of Intravenous Levetiracetam Use in Turkey
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, cilt.29, sa.4, ss.698-704, 2012 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 29 Sayı: 4
- Basım Tarihi: 2012
- Dergi Adı: JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.698-704
- İstanbul Üniversitesi Adresli: Evet
Özet
Objective: Status epilepticus is a neurological emergency feature with a risk of high mortality and morbidity which requires immediate intervention. Many of the medications used in standard treatment have systemic side effects. Levetiracetam (LEV) is one of the new antiepileptic agents which are not metabolized through the liver and have minimal drug interaction. Positive outcomes with intravenous (IV) form of LEV on patients with refractory seizures and status have been reported.